Jian et al. (34) found a high level of METTL14 expression in tumor necrosis factor-alpha-induced endothelial cells, indicating that METTL14 may have therapeutic potential in the treatment of endothelial dysfunction. Here, METTL14 is linked to endothelial dysfunction.